Pegsitacianine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Pegsitacianine, covering 2024-11-08 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY) [Phase 2]